Price Alert

VYNE Therapeutics Inc. (VYNE)

NASDAQ: VYNE · Real-Time Price · USD

0.40

-1.04 (-72.22%)

At close: Jul 30, 2025, 3:59 PM

VYNE Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	28.21M	19.93M	16.27M	29.66M	19.12M	30.67M	15.45M	20.63M	30.21M	30.91M	35.51M	42.81M	50.49M	42.25M	52.31M	103.41M	118.52M
Short-Term Investments	22.06M	41.59M	53.91M	48.49M	66.89M	62.63M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.03M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.34M	2.26M	2.54M	2.72M	1.27M	1.51M	1.76M	2M	2.24M	2.2M	2.73M	2.97M	3.35M	3.51M	3.68M	3.83M	4.12M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	250K	234K	105K	5.17M	5.47M	5.3M	5.54M	7.58M	10.08M	10.87M	10.76M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	54K	67K	n/a	97K	67K	n/a	4.5M	7.29M	8.07M	8.28M	8.09M
Other Current Assets	4.64M	2.92M	3.35M	5.67M	4.22M	2.71M	1.76M	2.02M	67K	n/a	67K	30K	729K	1.5M	605K	605K	855K
Total Current Assets	54.91M	64.44M	73.53M	83.78M	90.22M	95.96M	17.51M	22.96M	33.02M	38.27M	44.05M	51.92M	60.65M	63.19M	76.13M	128.43M	143.12M
Property-Plant & Equipment	169K	206K	122K	151K	180K	207K	n/a	n/a	n/a	282K	127K	298K	310K	354K	1.51M	1.73M	1.94M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.51M	2.47M	2.66M	2.87M	1.45M	1.72M	1.76M	2M	2.24M	2.48M	2.86M	3.27M	3.67M	3.86M	5.19M	5.56M	6.05M
Total Assets	56.42M	66.91M	76.2M	86.65M	91.68M	97.69M	19.27M	24.96M	35.26M	40.76M	46.91M	55.19M	64.32M	67.05M	81.31M	133.98M	149.17M
Account Payables	n/a	2.71M	3.99M	4.52M	2.79M	1.66M	716K	1.16M	2.21M	2.39M	2.52M	1.43M	3.61M	6.51M	7.62M	10.08M	3.49M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	12.99M	13.63M	17.31M
Short-Term Debt	63K	n/a	n/a	120K	n/a	115K	n/a	n/a	n/a	n/a	n/a	31K	117K	n/a	277K	33.38M	647K
Other Current Liabilities	12.23M	2.74M	8.55M	6.26M	3.64M	4M	4.45M	4.38M	4.39M	4.59M	2.37M	3.74M	3.41M	8.8M	9.44M	10.25M	12.98M
Total Current Liabilities	12.29M	14.82M	12.66M	11.75M	6.93M	7.54M	6.45M	6.37M	7.52M	9.35M	6.84M	6.83M	8.59M	18.41M	21M	57.62M	21.55M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	33.27M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	1.31M	1.31M	1.31M	1.31M	1.31M	211K	n/a	n/a	n/a	n/a	657K	658K	663K
Total Long-Term Liabilities	n/a	n/a	n/a	25K	1.38M	1.41M	1.31M	1.31M	1.31M	211K	n/a	6.8M	3.73M	6.86M	1.43M	1.47M	34.72M
Total Liabilities	12.29M	14.82M	12.66M	11.78M	8.31M	8.95M	7.76M	7.69M	8.83M	9.56M	6.84M	6.83M	8.59M	18.41M	22.43M	59.09M	56.27M
Total Debt	63K	99K	123K	145K	180K	214K	n/a	n/a	n/a	-349K	n/a	31K	117K	349K	1.05M	34.62M	34.7M
Common Stock	2K	1K	1K	1K	1K	1K	n/a	n/a	n/a	1.47M	6K	6K	6K	5K	5K	5K	5K
Retained Earnings	-739.78M	-731.17M	-719.15M	-706.99M	-697.59M	-691.34M	-685.15M	-678.56M	-668.51M	-662.74M	-652.79M	-643.33M	-634.86M	-639.52M	-627.96M	-606.67M	-586.75M
Comprehensive Income	n/a	20K	34K	-58K	-70K	26K	n/a	n/a	n/a	-211K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	44.13M	52.09M	63.54M	74.87M	83.37M	88.73M	11.51M	17.27M	26.43M	31.2M	40.07M	48.36M	55.73M	48.64M	58.89M	74.89M	92.9M
Total Investments	n/a	41.59M	53.91M	48.49M	66.89M	62.63M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.03M